April 21, 2026
The osteoarthritis therapeutics market size is expected to see growth from USD 11.92 billion in 2026 to USD 24...
Read MoreJune 04, 2026
The simulators market size is forecast to increase from USD 14.71 billion in 2026 to USD 27.59 billion by 2035...
Read MoreApril 21, 2026
The cardiometabolic diseases market size is anticipated to grow from USD 292.04 billion in 2026 to USD 1987.69...
Read MoreApril 21, 2026
The hospital services market is predicted to grow from USD 13.19 trillion in 2026 to USD 28.99 trillion by 203...
Read MoreApril 21, 2026
Projections indicate that, Latin America Behavioral Health industry is projected to rise from USD 5.2 billion in 2024 to USD 9.98 billion by 2034, reflecting a CAGR of 6.74% over the next decade. The market is growing due to rising mental health awareness and digital therapy adoption. In Latin America, growth is driven by expanding healthcare acces...
April 21, 2026
According to market projections, the respiratory health supplements sector is expected to grow from USD 8.78 billion in 2025 to USD 18.52 billion by 2035, reflecting a CAGR of 7.75%. The respiratory health supplements market is growing due to rising pollution leading to respiratory disorders. Asia Pacific dominated the market due to a large geriatr...
April 21, 2026
According to forecasts, the global myasthenia gravis treatment market will grow from USD 1.55 billion in 2024 to USD 3.29 billion by 2034, with an expected CAGR of 7.84%. The myasthenia gravis treatment market is growing due to the rising prevalence of myasthenia gravis (MG), the growing aging population, and enhanced diagnostic abilities. North Am...
April 21, 2026
The cell and gene therapy infrastructure market is growing due to advances in gene editing technology and the increasing prevalence of genetic and chronic diseases. North America is dominant in the market due to the robust public and private spending....
April 21, 2026
The inhaled therapy in respiratory disease market is valued at USD 11.98 billion in 2025 and expected to reach USD 16.22 billion by 2034 at 3.44% CAGR. Dominant segments include bronchodilators (28%), MDIs (35%), COPD (38%), retail pharmacies (60%), and inhaled biologics growing fastest. North America holds 42% share, Asia Pacific fastest-growing. ...
April 21, 2026
According to market projections, the gene therapies for cancer treatment sector is expected to grow from USD 8.28 billion in 2024 to USD 238.77 billion by 2034, reflecting a CAGR of 39.94%. The rising prevalence of cancer and the growing demand for personalized medicines drive the global market. North America dominated due to the availability of st...
April 21, 2026
According to market projections, the global modified antibody market, valued at USD 3.10 billion in 2025, is anticipated to reach USD 7.36 billion by 2035, growing at a CAGR of 9.04% over the next decade. The biopharmaceutical contract manufacturing market is growing rapidly, fueled by rising outsourcing and biologics demand. The report includes ...
April 21, 2026
According to market projections, the global anticancer drugs market, valued at USD 167.09 billion in 2024, is anticipated to reach USD 401.32 billion by 2034, growing at a CAGR of 9.14% over the next decade. The growing aging population is more susceptible to cancer, increasing the patient pool for anti-cancer drugs. North America led the global ma...
April 21, 2026
According to market projections, the global generic drug CRO market, valued at USD 8.45 billion in 2024, is anticipated to reach USD 11.73 billion by 2034, growing at a CAGR of 3.36% over the next decade. The generic drug CRO market is growing due to increasing demand for affordable healthcare services and the expiration of patents on major medicin...
April 21, 2026
Based on market forecasts, the biosynthesis peptide drugs sector will expand from USD 18.31 billion in 2024 to USD 32.88 billion by 2034, experiencing a CAGR of 6.26%. The biosynthesis peptide drugs market is growing, as these drugs offer many advantages, such as low manufacturing cost, reduced contamination, and a simpler manufacturing process tha...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
